Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Tretinoin and Sirolimus

supplement:

Tretinoin

Research Papers that Mention the Interaction

However, combined use of rapamycin and all-trans retinoic acid abolishes IL-17 production and confers a specific chemokine receptor homing profile upon regulatory T cells.
Haematologica  •  2013  |  View Paper
The enhancing effects of retinoids on the proliferative response of PMA-stimulated PBMCs were reversed by rapamycin (10 ng/ml), an immunosuppressant known to inhibit the phorbol ester-induced protein kinase C pathway of lymphocyte activation.
Archives of Dermatological Research  •  1998  |  View Paper
ATRA activated p70S6k1 in MSCs in vitro, which was completely inhibited by rapamycin.
Stem cells translational medicine  •  2018  |  View Paper
Based on our data, translational studies could confirm whether combination of RA with reduced dosage of rapamycin would have more beneficial effects to higher dosage of rapamycin monotherapy meanwhile reducing adverse effects of rapamycin for patients with TSC mutation.
Frontiers in Oncology  •  2021  |  View Paper
Results:Ex-vivo … of TRA significantly induced the expression of a4b7 compared to Rapamycin alone (5.57%±3.12 vs …=0.0057) Cells treated with Rapa+ATRA maintained their superior suppressive ability compared to R apamycin treated Tregs (95.8%±3.5% vs 91.…; at Treg:Teff 1:1 ratio).
Journal of Crohn's & colitis  •  2017  |  View Paper
To conclude, (i) pharmacological characterization of PI3K-Akt-mTOR inhibitors requires carefully standardized experimental models, (ii) rapamycin effects differ … patients, and (iii) combined targeting of different steps in this pathway should be further investigated whereas combination of rapamycin with valproic acid, ATRA , or NF-κB inhibitors seems less promising.
Bone marrow research  •  2012  |  View Paper